SCIWIND

Sciwind Biosciences (Hangzhou Sciwind Biosciences Co., Ltd.) is a commercial-stage biopharmaceutical company headquartered in Hangzhou, China, with a US office in San Ramon, California, focused on discovering, developing, and delivering innovative therapeutics for weight management and metabolic disease. Its pipeline spans obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH), led by the GLP-1 receptor agonist Ecnoglutide (advancing through Phase III trials). The company operates proprietary drug-discovery platforms including BiasVantage (biased agonist discovery), OralVantage (oral peptide delivery), and HaleVantage (half-life extension), with 14+ pipeline programs, 120+ researchers, and 110+ patents. Surfaced as a portfolio company of IDG Capital and added to the API Evangelist network; enrichment found no public API or developer platform surface.

SCIWIND is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biopharmaceutical, Biotechnology, and Pharmaceuticals.

SCIWIND’s developer surface includes product news and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareBiopharmaceuticalBiotechnologyPharmaceuticalsDrug DiscoveryMetabolic DiseaseWeight Management

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/sciwind: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Sciwind Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 News
News

Source (apis.yml)

apis.yml Raw ↑ 
aid: sciwind
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/sciwind.png
name: SCIWIND
description: Sciwind Biosciences (Hangzhou Sciwind Biosciences Co., Ltd.) is a commercial-stage biopharmaceutical company
  headquartered in Hangzhou, China, with a US office in San Ramon, California, focused on discovering, developing, and delivering
  innovative therapeutics for weight management and metabolic disease. Its pipeline spans obesity, type 2 diabetes, and non-alcoholic
  steatohepatitis (NASH), led by the GLP-1 receptor agonist Ecnoglutide (advancing through Phase III trials). The company
  operates proprietary drug-discovery platforms including BiasVantage (biased agonist discovery), OralVantage (oral peptide
  delivery), and HaleVantage (half-life extension), with 14+ pipeline programs, 120+ researchers, and 110+ patents. Surfaced
  as a portfolio company of IDG Capital and added to the API Evangelist network; enrichment found no public API or developer
  platform surface.
url: https://raw.githubusercontent.com/api-evangelist/sciwind/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1
tags:
- Company
- Healthcare
- Biopharmaceutical
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Metabolic Disease
- Weight Management
common:
- type: DomainSecurity
  url: security/sciwind-domain-security.yml
- type: Website
  url: https://www.sciwindbio.com/
- type: News
  url: https://www.sciwindbio.com/portal/index/news/category_id/5.html
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io